A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Condition: Malignant Melanoma, NeoplasmsInterventions: Drug: ketoconazole; Drug: vemurafenibSponsor: Hoffmann-La RocheWithdrawn - verified November 2014

http://clinicaltrials.gov/ct2/show/NCT01765556?lup_s=10%2F11%2F2014&lup_d=30

Source: ClinicalTrials.gov - January 9, 2013 Category: Research Source Type: clinical trials